PULM Pulmatrix Inc

Pulmatrix Inc is is a clinical stage biotechnology company. The Company is engaged in discovery and development of a novel class of inhaled therapeutic products intended to prevent and treat respiratory diseases and infections.

As of 07/23/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/21/2014
Outstanding shares:  56,249,062
Average volume:  429,074
Market cap:   $50,506,033
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    74584P202
ISIN:        US74584P2020
Sedol:      BJHTCB7
Valuation   (See tab for details)
PE ratio:   -2.67
PB ratio:   1.21
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy